LFCR - LIFECORE BIOMEDICAL, INC. \DE\
IEX Last Trade
7.275
-0.215 -2.955%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:47 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$7.49
-0.22
-2.87%
View ratios
| Fiscal Date | 2021-08-29 | 2021-11-28 | 2022-02-27 | 2022-05-29 | 2022-08-28 | 2022-11-27 | 2023-02-26 | 2023-05-28 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2021-10-05 | 2022-01-07 | 2022-04-07 | 2022-09-14 | 2022-10-07 | 2023-03-16 | 2023-06-02 | 2024-03-20 | |
| Total revenue | 128.788 M | 129.492 M | 53.074 M | -125.568 M | 43.355 M | 38.802 M | 27.600 M | -6.488 M | |
| Cost of revenue | 111.269 M | 116.500 M | 39.179 M | -131.532 M | 37.534 M | 31.694 M | 21.622 M | -15.135 M | |
| Gross profit | 17.519 M | 12.992 M | 13.895 M | 5.964 M | 5.821 M | 7.108 M | 5.978 M | 8.647 M | |
| -25.84% | 6.95% | -57.08% | -2.40% | 22.11% | -15.90% | 44.65% | |||
| Operating expenses | 18.765 M | 16.553 M | 11.781 M | 6.869 M | 12.931 M | 12.891 M | 12.936 M | 9.169 M | |
| Selling general and admin | 15.939 M | 13.835 M | 9.725 M | 6.628 M | 10.883 M | 10.773 M | 10.972 M | 6.563 M | |
| Research and development | 2.826 M | 2.718 M | 2.056 M | 241.000 K | 2.048 M | 2.118 M | 1.964 M | 2.606 M | |
| Total expenses | 130.034 M | 133.053 M | 50.960 M | -124.663 M | 50.465 M | 44.585 M | 34.558 M | -5.966 M | |
| 2.32% | -61.70% | -344.63% | 140.48% | -11.65% | -22.49% | -117.26% | |||
| Operating income | -1.246 M | -3.561 M | 2.114 M | -905.000 K | -7.110 M | -5.783 M | -6.958 M | -522.000 K | |
| Ebit | -1.246 M | -3.561 M | 2.114 M | -905.000 K | -7.110 M | -5.783 M | -6.958 M | -522.000 K | |
| Pretax income | -11.589 M | -41.265 M | -7.382 M | 8.121 M | -12.000 M | -12.445 M | -15.391 M | -24.745 M | |
| 256.07% | -82.11% | -210.01% | -247.77% | 3.71% | 23.67% | 60.78% | |||
| Income tax | -2.112 M | -2.824 M | -276.000 K | -627.000 K | 64.000 K | 4.000 K | 70.000 K | 230.000 K | |
| Net income basic | -9.477 M | -38.441 M | -12.850 M | -36.663 M | -12.064 M | -12.449 M | -40.192 M | -35.571 M | |
| -305.62% | 66.57% | -185.32% | 67.09% | -3.19% | -222.85% | 11.50% | |||
| Net income | -9.477 M | -38.441 M | -12.850 M | -36.663 M | -12.064 M | -12.449 M | -40.192 M | -35.571 M | |
| -305.62% | 66.57% | -185.32% | 67.09% | -3.19% | -222.85% | 11.50% |